60
Participants
Start Date
December 7, 2018
Primary Completion Date
September 1, 2023
Study Completion Date
September 1, 2023
GnRH agonist
Zoladex is a gonadotropin-releasing hormone agonist, or GnRH-A. It is an implant that is injected under the skin (subcutaneously). The implant gradually dissolves and releases the drug over the time between injections. There are two dosages of Zoladex: Zoladex 10.8 mg, which is injected once every 3 months, and Zoladex 3.6 mg, which is injected once a month.
Veterans Affairs Puget Sound Health Care System, Seattle
United States Department of Defense
FED
University of Washington
OTHER
Seattle Institute for Biomedical and Clinical Research
OTHER